NKE
NIKE, Inc.
NKE has the edge over PHM overall, supported by stronger valuation and stronger modeled upside.
PHM
PulteGroup, Inc.
PHM trails on the overall score without a compensating advantage in the available component scores.
NKE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
PHM Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Stable | |
| Stable | |
| Strong |
PHM's balance sheet is currently strong, and its profitability and cash flow are stable, but its revenue is under pressure.
NKE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $37.76 | — |
| Cheap | 23x | $47.70 | +26% |
| Forward | 30x | $37.76 | — |
| Fair | 33x | $68.16 | +80% |
| Expensive | 47x | $97.86 | +159% |
Historical ranges are pointers, not guarantees.
NKE has the edge over PHM in the historical PE scenario, which offers more potential upside but is not a forecast.
PHM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 5.8x | $54.71 | -57% |
| Fair | 8.8x | $82.04 | -35% |
| Expensive | 11x | $99.83 | -21% |
| Current | 14x | $127 | — |
| Forward | 14x | $127 | — |
Historical ranges are pointers, not guarantees.
PHM's PE is in its expensive range at 13.6x. On analysts' estimates for next year's earnings, today's price would be 13.7x.
NKE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Decline | |
| Improving | |
| Moderate | |
| Low |
Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
PHM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Weakening | |
| Limited | |
| Low |
Analysts expect PHM's profitability to weaken, with its earnings and revenue holding steady. However, they disagree widely on these estimates.
NKE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | -39% |
| Q3 2026 | $2.09 | +7.2% |
| Q2 2026 | $2.10 | -2.8% |
| Q1 2026 | $1.51 | -50% |
| Q4 2025 | $1.70 | -48% |
| Q3 2025 | $1.95 | -44% |
| Q2 2025 | $2.16 | -42% |
| Q1 2025 | $3.01 | -11% |
| Q4 2024 | $3.24 | -5.3% |
NKE's earnings per share have fallen from their peak: $2.09 over the past year, against $3.82 in late 2021.
PHM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.29 | -0.7% |
| Q3 2026 | $9.36 | -28% |
| Q2 2026 | $9.79 | -27% |
| Q1 2026 | $10.34 | -27% |
| Q4 2025 | $11.12 | -24% |
| Q3 2025 | $12.97 | -4.2% |
| Q2 2025 | $13.36 | +2.1% |
| Q1 2025 | $14.16 | +14% |
| Q4 2024 | $14.69 | +25% |
PHM has the edge over NKE on earnings, with more consistent year-over-year improvement.
NKE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.2B | -4.3% |
| Q2 2026 | $11B | -1.1% |
| Q1 2026 | $11.3B | +0.1% |
| Q4 2025 | $12.4B | +0.6% |
| Q3 2025 | $11.7B | +1.1% |
| Q2 2025 | $11.1B | -12% |
| Q1 2025 | $11.3B | -9.3% |
| Q4 2024 | $12.4B | -7.7% |
NKE has the edge over PHM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.3 points |
| Q2 2026 | 12% | +9.2 points |
| Q1 2026 | 5.8% | -1.7 points |
| Q4 2025 | 8% | -3.4 points |
| Q3 2025 | 7.9% | -3.4 points |
| Q2 2025 | 2.9% | -11 points |
| Q1 2025 | 7.5% | -3.8 points |
| Q4 2024 | 11% | -2.9 points |
NKE's operating margin was 8.2% last quarter, about level with the same quarter a year ago.
PHM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4B | -9.8% |
| Q2 2026 | $4B | -9.6% |
| Q1 2026 | $3.4B | -12% |
| Q4 2025 | $4.6B | -6.3% |
| Q3 2025 | $4.4B | -1.6% |
| Q2 2025 | $4.4B | -4.3% |
| Q1 2025 | $3.9B | -1.4% |
| Q4 2024 | $4.9B | +15% |
PHM's revenue has slid since its 2022 peak: $4B last quarter, down 9.8% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 16% | -1.7 points |
| Q2 2026 | 16% | -2.7 points |
| Q1 2026 | 13% | -4.3 points |
| Q4 2025 | 14% | -9.8 points |
| Q3 2025 | 17% | -2.8 points |
| Q2 2025 | 18% | -4.5 points |
| Q1 2025 | 18% | -4.5 points |
| Q4 2024 | 24% | +2 points |
PHM has the edge over NKE on profitability, with a higher operating margin.
NKE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$64M | -527% |
| Q2 2026 | $1.5B | +313% |
| Q1 2026 | $284M | -83% |
| Q4 2025 | $386M | -58% |
| Q3 2025 | $15M | -95% |
| Q2 2025 | $363M | -85% |
| Q1 2025 | $1.7B | -11% |
| Q4 2024 | $920M | -65% |
NKE usually generates cash, though not every quarter: the latest was −$64M, but it generated $2.1B over the past year.
PHM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $437.2M | -33% |
| Q2 2026 | -$12.9M | -105% |
| Q1 2026 | $134.4M | +28% |
| Q4 2025 | $739.8M | +36% |
| Q3 2025 | $651.1M | +56% |
| Q2 2025 | $253M | -35% |
| Q1 2025 | $104.6M | -51% |
| Q4 2024 | $543.1M | +106% |
PHM has the edge over NKE on cash flow, with more consistent year-over-year improvement.
NKE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +3.2M shares |
| 1 year | +0.4% | +5.2M shares |
| 3 years | -3.8% | -59.1M shares |
| 5 years | -8.4% | -135M shares |
| Available history | -6.9% | -110M shares |
NKE has 1.5B diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $20M |
| Q3 2025 | $126M |
| Q2 2025 | $199M |
| Q1 2025 | $506M |
| Q4 2024 | $1.1B |
NKE has spent almost nothing on buybacks in the past year.
PHM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1.4% | -2.7M shares |
| 1 year | -5.2% | -10.3M shares |
| 3 years | -14% | -31.8M shares |
| 5 years | -27% | -71.1M shares |
| Available history | -31% | -83.6M shares |
PHM has the edge over NKE on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $350.4M |
| Q2 2026 | $373M |
| Q1 2026 | $308.2M |
| Q4 2025 | $300M |
| Q3 2025 | $300M |
| Q2 2025 | $300M |
| Q1 2025 | $300M |
| Q4 2024 | $320M |
PHM spent $1.3B buying back its own shares over the past year, up 9.1% from the year before.
NKE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.2x | Very low |
| Q3 2024 | 0.1x | Very low |
| Q2 2024 | -0.1x | Net Cash |
| Q1 2024 | -0.0x | Very low |
| Q4 2023 | 0.1x | Very low |
NKE's net debt is less than a year of its operating earnings (EBITDA).
PHM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | -0.6x | Net Cash |
| Q3 2025 | 0.0x | Very low |
| Q2 2025 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | -0.4x | Net Cash |
PHM's net debt is less than a year of its operating earnings (EBITDA).
NKE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 57.5 | Neutral |
NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).
PHM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 53.2 | Neutral |
| Stochastic | 66.1 | Neutral |
PHM's weekly RSI is 53 (neutral) and its Stochastic is 66 (neutral).
NKE PE vs Consumer Cyclical Sector
| Metric | NKE | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.3% above |
| PE % | 2 | 47 | 45 pts below |
NKE is trading at 18x earnings, in line with the Consumer Cyclical sector's median of 18x.
PHM PE vs Consumer Cyclical Sector
| Metric | PHM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 18x | 25% below |
| PE % | 99 | 47 | 52 pts above |
PHM has the edge over NKE on valuation relative to its sector.
NKE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.7 | 2.8% above |
| 20 week MA | $39.2 | 3.6% below |
| 50 week MA | $48.0 | 21% below |
| 100 week MA | $58.4 | 35% below |
| 200 week MA | $79.2 | 52% below |
NKE has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 52% below its 200-week average.
PHM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $120.8 | 5% above |
| 20 week MA | $124.3 | 2.1% above |
| 50 week MA | $124.4 | 2% above |
| 100 week MA | $118.8 | 6.8% above |
| 200 week MA | $107.7 | 18% above |
PHM has the edge over NKE on trend strength, trading above more of its moving averages.
NKE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $101.6 | $141.6 | +39% |
| 2021 | $141.6 | $165.7 | +17% |
| 2022 | $165.7 | $116.3 | -30% |
| 2023 | $116.3 | $108.6 | -6.6% |
| 2024 | $108.6 | $76.4 | -30% |
| 2025 | $76.4 | $60.9 | -20% |
| 2026 YTD | $60.9 | $37.8 | -38% |
NKE has finished four years in a row lower, and it's down 38% so far in 2026.
PHM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $38.8 | $45.2 | +17% |
| 2021 | $45.2 | $54.7 | +21% |
| 2022 | $54.7 | $45.8 | -16% |
| 2023 | $45.8 | $103.2 | +125% |
| 2024 | $103.2 | $109.5 | +6.1% |
| 2025 | $109.5 | $119.2 | +8.8% |
| 2026 YTD | $119.2 | $126.9 | +6.5% |
PHM has the edge over NKE on returns for 2026, with the stronger performance.